ANIXA BIOSCIENCES, INC. License and Services Revenue (Deprecated 2018-01-31)
ANIXA BIOSCIENCES, INC. (ANIX) reported License and Services Revenue (Deprecated 2018-01-31) of $1.19 million for the 12-month period ending 2014-10-31, per its 10-K filed 2015-12-23.
Discontinued › Income Statement › Other Income
us-gaap:LicenseAndServicesRevenue · last filed 2015-12-23
- ANIXA BIOSCIENCES, INC. license and services revenue (deprecated 2018-01-31) for the quarter ending 2014-10-31 was $0.00.
- ANIXA BIOSCIENCES, INC. license and services revenue (deprecated 2018-01-31) for the quarter ending 2014-07-31 was $1.19M.
- ANIXA BIOSCIENCES, INC. license and services revenue (deprecated 2018-01-31) for the quarter ending 2012-10-31 was $0.00, a 100.00% decline year-over-year.
- ANIXA BIOSCIENCES, INC. license and services revenue (deprecated 2018-01-31) for the quarter ending 2012-07-31 was $246.67K, a 42.10% decline year-over-year.
- ANIXA BIOSCIENCES, INC. license and services revenue (deprecated 2018-01-31) for fiscal 2014 was $1.19M.
- ANIXA BIOSCIENCES, INC. license and services revenue (deprecated 2018-01-31) for fiscal 2013 was $0.00, a 100.00% decline from fiscal 2012.
- ANIXA BIOSCIENCES, INC. license and services revenue (deprecated 2018-01-31) for fiscal 2012 was $940.01K, a 7.72% increase from fiscal 2011.
- ANIXA BIOSCIENCES, INC. license and services revenue (deprecated 2018-01-31) for fiscal 2011 was $872.67K, a 45.45% increase from fiscal 2010.
| Period end | License and Services Revenue (Deprecated 2018-01-31) 3 month | License and Services Revenue (Deprecated 2018-01-31) 6 month | License and Services Revenue (Deprecated 2018-01-31) 9 month | License and Services Revenue (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2014-10-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-23 | $1.19M derived: sum of 2 quarters · filed 2015-12-23 | $1.19M 10-K · filed 2015-12-23 | |
| 2014-07-31 | $1.19M 10-Q · filed 2015-08-18 | $1.19M 10-Q · filed 2015-08-18 | ||
| 2013-10-31 | $0.00 10-K/A · filed 2014-01-17 | |||
| 2012-10-31 | $0.00 derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2014-01-17 | $246.67K derived: sum of 2 quarters · filed 2014-01-17 | $493.34K derived: sum of 3 quarters · filed 2014-01-17 | $940.01K 10-K/A · filed 2014-01-17 |
| 2012-07-31 | $246.67K 10-Q/A · filed 2013-09-20 | $493.34K derived: sum of 2 quarters · filed 2013-09-20 | $940.01K 10-Q/A · filed 2013-09-20 | $1.39M derived: sum of 4 quarters · filed 2013-09-20 |
| 2012-04-30 | $246.67K 10-Q/A · filed 2013-06-19 | $693.34K 10-Q/A · filed 2013-06-19 | $1.14M derived: sum of 3 quarters · filed 2013-06-19 | $1.57M derived: sum of 4 quarters · filed 2013-06-19 |
| 2012-01-31 | $446.67K 10-Q/A · filed 2013-03-25 | $893.34K derived: sum of 2 quarters · filed 2013-03-25 | $1.32M derived: sum of 3 quarters · filed 2013-03-25 | |
| 2011-10-31 | $446.67K derived: 10-K 12 month − 10-Q 9 month · filed 2013-01-29 | $872.67K derived: sum of 2 quarters · filed 2013-01-29 | $872.67K 10-K · filed 2013-01-29 | |
| 2011-07-31 | $426.00K 10-Q · filed 2012-09-14 | $426.00K 10-Q · filed 2012-09-14 | ||
| 2010-10-31 | $300.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2012-01-30 | $600.00K 10-K · filed 2012-01-30 | ||
| 2010-07-31 | $300.00K 10-Q/A · filed 2011-10-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |